Ketamine
- Generic Name
- Ketamine
- Brand Names
- Ketalar
- Drug Type
- Small Molecule
- Chemical Formula
- C13H16ClNO
- CAS Number
- 6740-88-1
- Unique Ingredient Identifier
- 690G0D6V8H
- Background
Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
- Indication
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia, Induction and Maintenance of General Anesthesia
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Yale University
- Target Recruit Count
- 162
- Registration Number
- NCT05737693
- Locations
- 🇮🇱
Tel Aviv University, Tel Aviv, Israel
🇺🇸Yale University School of Medicine, New Haven, Connecticut, United States
A Comparative Evaluation of Nebulized Dexmedetomidine and Nebulized Ketamine as a Premedication in Pediatric Surgeries
- Conditions
- Interventions
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 60
- Registration Number
- NCT05719506
- Locations
- 🇪🇬
Tanta University Hospitals, Tanta, Egypt
🇪🇬Tanta University, Tanta, Egypt
Prevention of Shivering After Spinal Anesthesia
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Pakistan Air Force (PAF) Hospital Islamabad
- Target Recruit Count
- 116
- Registration Number
- NCT05718011
- Locations
- 🇵🇰
PAF Hospital Islamabad, Islamabad, Federal, Pakistan
Scheduled Intranasal Ketamine
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Sanford Health
- Registration Number
- NCT05671913
Ketamine for the Treatment for Alcohol Use Disorder in the ED
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT05661669
- Locations
- 🇺🇸
Brigham and Women's Faulkner Hospital, Boston, Massachusetts, United States
Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10
- Conditions
- Interventions
- First Posted Date
- 2022-12-13
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Universitas Sumatera Utara
- Target Recruit Count
- 42
- Registration Number
- NCT05648526
- Locations
- 🇮🇩
Faculty of Medicine Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia
Predictors of Intravenous Ketamine Response in TRD
- Conditions
- Interventions
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Abraham Nunes
- Target Recruit Count
- 40
- Registration Number
- NCT05625555
- Locations
- 🇨🇦
Mood Disorders Program, Halifax, Nova Scotia, Canada
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
- Conditions
- Interventions
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT05597878
- Locations
- 🇺🇸
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Analgesic Effect of Ketamine Vs Ketamine Magnesium Infusion and Their Effect on Postoperative Morphine Consumption
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Egymedicalpedia
- Target Recruit Count
- 100
- Registration Number
- NCT05596669
- Locations
- 🇪🇬
October 6 University Hospital, Giza, Egypt
Ketamine and Stress in OCD
- Conditions
- Interventions
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT05577585
- Locations
- 🇦🇹
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.